Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.7554/elife.93243.3

Type

Journal

eLife

Publisher

eLife

Publication Date

09/09/2024

Volume

13

Keywords

Infectious Diseases, Infection, Emerging Infectious Diseases, 5.1 Pharmaceuticals, Rare Diseases, Tuberculosis, Biodefense, Orphan Drug, 3 Good Health and Well Being, 31 Biological Sciences, 6.1 Pharmaceuticals, Antimicrobial Resistance, 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences